Evidence map›Paper›PMID 35754492›Full record

ArticleFrontiers in pharmacology2022

Modeling Kaempferol as a Potential Pharmacological Agent for COVID-19/PF Co-Occurrence Based on Bioinformatics and System Pharmacological Tools.

Yong Jiang, Yi-Zi Xie, Chen-Wen Peng, Kai-Nan Yao, Xue-Ying Lin, Shao-Feng Zhan, Hong-Fa Zhuang, Hui-Ting Huang, Xiao-Hong Liu, Xiu-Fang Huang and 1 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pharmacology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Identification of active compounds inFrontiers in pharmacology · 2024
    Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Yong JiangShenzhen Hospital of Integrated Traditional Chinese and Western Medicine, Shenzhen, China.
Yi-Zi XieThe First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.
Chen-Wen PengThe First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.
Kai-Nan YaoShenzhen Bao'an District Traditional Chinese Medicine Hospital, Guangzhou University of Chinese Medicine, Shenzhen, China.
Xue-Ying LinThe First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.
Shao-Feng ZhanThe First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.
Hong-Fa ZhuangThe First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.
Hui-Ting HuangThe First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.
Xiao-Hong LiuThe First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.
Xiu-Fang HuangThe First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.
Hang LiShenzhen Bao'an District Traditional Chinese Medicine Hospital, Guangzhou University of Chinese Medicine, Shenzhen, China.
First Affiliated Hospital of Guangzhou University of Chinese Medicine · CNGuangzhou University of Chinese Medicine · CNShenzhen Pingle Orthopedic Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

bioinformatic analysisco-occurrenceCOVID-19kaempferolpulmonary fibrosissystem pharmacology

Identifiers

PMID35754492
PMCPMC9214245
OpenAlexW4285742959

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.